FDA campaign H-0603-2025
Class IIHazard
Product manufactured under insanitary conditions whereby it may have been contaminated with Cesium-137 (Cs-137)
Distribution
Product was distriburted to the following states: Alabama, Arizona, California, Massachusetts, Minnesota, Pennsylvania, Utah, Virginia, and Washington state. No foreign distribution.
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.